NLTX · Categories · 13G

NLTX - SEC Schedule 13G filings

Neoleukin Therapeutics Inc. (NLTX) sec schedule 13g filings - real-time wire coverage filtered to 13G only.

Recent 13G for NLTX

• 847d
  SEC Form SC 13G filed by Neoleukin Therapeutics Inc.

  SC 13G - Neurogene Inc. (0001404644) (Subject)
• 847d
  SEC Form SC 13G/A filed by Neoleukin Therapeutics Inc. (Amendment)

  SC 13G/A - Neurogene Inc. (0001404644) (Subject)
• 847d
  SEC Form SC 13G/A filed by Neoleukin Therapeutics Inc. (Amendment)

  SC 13G/A - Neurogene Inc. (0001404644) (Subject)
• 847d
  SEC Form SC 13G filed by Neoleukin Therapeutics Inc.

  SC 13G - Neurogene Inc. (0001404644) (Subject)
• 847d
  SEC Form SC 13G filed by Neoleukin Therapeutics Inc.

  SC 13G - Neurogene Inc. (0001404644) (Subject)
• 848d
  SEC Form SC 13G filed by Neoleukin Therapeutics Inc.

  SC 13G - Neurogene Inc. (0001404644) (Subject)
• 848d
  SEC Form SC 13G/A filed by Neoleukin Therapeutics Inc. (Amendment)

  SC 13G/A - Neurogene Inc. (0001404644) (Subject)
• 896d
  SEC Form SC 13G filed by Neoleukin Therapeutics Inc.

  SC 13G - Neurogene Inc. (0001404644) (Subject)
• 901d
  SEC Form SC 13G/A filed by Neoleukin Therapeutics Inc. (Amendment)

  SC 13G/A - Neurogene Inc. (0001404644) (Subject)
• 1212d
  SEC Form SC 13G/A filed by Neoleukin Therapeutics Inc. (Amendment)

  SC 13G/A - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1224d
  SEC Form SC 13G filed by Neoleukin Therapeutics Inc.

  SC 13G - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1238d
  SEC Form SC 13G/A filed by Neoleukin Therapeutics Inc. (Amendment)

  SC 13G/A - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1258d
  SEC Form SC 13G filed by Neoleukin Therapeutics Inc.

  SC 13G - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1422d
  SEC Form SC 13G filed by Neoleukin Therapeutics Inc.

  SC 13G - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1426d
  SEC Form SC 13G filed by Neoleukin Therapeutics Inc.

  SC 13G - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1433d
  SEC Form SC 13G filed by Neoleukin Therapeutics Inc.

  SC 13G - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1434d
  SEC Form SC 13G filed by Neoleukin Therapeutics Inc.

  SC 13G - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1577d
  SEC Form SC 13G/A filed by Neoleukin Therapeutics Inc. (Amendment)

  SC 13G/A - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1580d
  SEC Form SC 13G/A filed by Neoleukin Therapeutics Inc. (Amendment)

  SC 13G/A - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1580d
  SEC Form SC 13G/A filed by Neoleukin Therapeutics Inc. (Amendment)

  SC 13G/A - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1582d
  SEC Form SC 13G filed by Neoleukin Therapeutics Inc.

  SC 13G - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1940d
  SEC Form SC 13G filed

  SC 13G - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1941d
  SEC Form SC 13G/A filed

  SC 13G/A - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1944d
  SEC Form SC 13G filed

  SC 13G - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1944d
  SEC Form SC 13G filed

  SC 13G - Neoleukin Therapeutics, Inc. (0001404644) (Subject)
• 1954d
  SEC Form SC 13G filed

  SC 13G - Neoleukin Therapeutics, Inc. (0001404644) (Subject)

Other NLTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends